TRACON Pharmaceuticals
1D
1W
1M
3M
1Y
5Y
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TCON and other ETFs, options, and stocks.About TCON
TRACON Pharmaceuticals, Inc. engages in the development and commercialization of targeted therapies for cancer, and ophthalmic and fibrotic diseases. Its products include TRC105, an anti-endoglin antibody for the treatment of solid tumor types, TRC205 created for the treatment of fibrotic diseases, and TRC102, a small molecule that is in clinical development made for lung cancer and glioblastoma.
CEOCharles P. Theuer
CEOCharles P. Theuer
Employees19
Employees19
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2004
Founded2004
Employees19
Employees19
TCON Key Statistics
Market cap37.32M
Market cap37.32M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume64.97K
Average volume64.97K
High today—
High today—
Low today—
Low today—
Open price$1.68
Open price$1.68
Volume0.00
Volume0.00
52 Week high$3.00
52 Week high$3.00
52 Week low$1.10
52 Week low$1.10
TCON Earnings
-$0.58
-$0.39
-$0.19
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated— per share
Estimated— per share
ActualExpected Mar 14, After Hours
ActualExpected Mar 14, After Hours